Zhejiang Jingxin Pharmaceutical Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Zhejiang Jingxin Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects (NCT06537050) | Zhejiang Jingxin Pharmaceutical Co., Ltd. | 2024-07-01 |
| A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. (NCT06356389) | Zhejiang Jingxin Pharmaceutical Co., Ltd. | 2022-03-02 |
| A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule (NCT05233657) | Zhejiang Jingxin Pharmaceutical Co., Ltd. | 2020-01-04 |
Track Zhejiang Jingxin Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.